EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pathologic outcome of incidentally detected tracer-avid lesions in 68Ga-PSMA-11 PET/CT for prostate cancer

Darryl Mar iD, Devan Diwanji, Blair Lowery, Li Zhang, Thomas A Hope iD, Spencer C Behr iD, Robert R Flavell iD

Radiology Advances · 2024

DOI: 10.1093/radadv/umae008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology Advances, 2024. Verfasst von Darryl Mar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, United States. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate-specific membrane antigen (PSMA) PET is effective in identifying prostate cancer metastases. However, PSMA PET uptake has also been described in other lesions, including nonprostate malignancies and benign processes.

Purpose

To identify causes of unexpected radiopharmaceutical accumulation on PSMA PET. Materials and Methods A total of 2,054 study reports representing 1,873 unique patients who had undergone 68Ga-PSMA-11 PET/CT scans at a single large academic center from December 2015 to April 2022 were retrospectively reviewed for the mention of unexpected PSMA uptake not initially thought to represent metastatic prostate cancer. Scans with pathologic outcome were reviewed by 2 blinded readers for scan indication and lesion location and quantitative parameters.

Results

In 48 patients, the PSMA ligand–avid incidental lesions revealed 19 cases of second malignancies, 17 cases of prostate cancer, and 13 cases of benign lesions. The most common lesion locations were lung (14), thyroid (14), lymph nodes (8), and bowel (4). Benign lesions exhibited lower molecular imaging PSMA scores (median: 1; interquartile range [IQR]: 1.00-1.25; P = .017) than metastatic prostate lesions (median: 2; IQR: 1-3). Second malignancies were larger (median: 34 mm; IQR: 27-39 mm) than metastatic prostate cancer (median: 14 mm; IQR: 12-19 mm; P = .001) and benign lesions (median: 19 mm; IQR: 13.00-31.00 mm; P = .03). PSMA ligand–avid lesions in scans performed in the initial staging for prostate cancer were more commonly associated with a diagnosis of a secondary malignancy than with metastatic prostate cancer (0 vs 8 lesions, P = .008). Higher standardized uptake value maximum was observed for metastatic prostate cancer and second malignancy when compared with benign outcome.

Conclusion

Features that influence the probability of an incidental lesion representing a malignancy include lesion location, reason for the PSMA PET/CT study, and associated imaging features (size, standardized uptake value maximum, and molecular imaging PSMA score).

Schlagwörter

Stichwörter der Autor:innen

PET/CTmolecular imagingprostate cancerprostate specific membrane antigen (PSMA)

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, United States.
  • Department of Medicine, University of California, San Francisco, CA 94143, United States.
  • Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158-2517, United States.

ORCID-Profile: Darryl Mar, Thomas A Hope, Spencer C Behr, Robert R Flavell

Zitieren

APA

Mar, D., Diwanji, D., Lowery, B., Zhang, L., Hope, T. A., Behr, S. C., & Flavell, R. R. (2024). Pathologic outcome of incidentally detected tracer-avid lesions in 68Ga-PSMA-11 PET/CT for prostate cancer. Radiology Advances. https://doi.org/10.1093/radadv/umae008

Vancouver

Mar D, Diwanji D, Lowery B, Zhang L, Hope TA, Behr SC, et al. Pathologic outcome of incidentally detected tracer-avid lesions in 68Ga-PSMA-11 PET/CT for prostate cancer. Radiology Advances. 2024. doi:10.1093/radadv/umae008

BibTeX
@article{Mar2024,
  author = {Mar, Darryl and Diwanji, Devan and Lowery, Blair and Zhang, Li and Hope, Thomas A and Behr, Spencer C and Flavell, Robert R},
  title = {Pathologic outcome of incidentally detected tracer-avid lesions in 68Ga-PSMA-11 PET/CT for prostate cancer},
  journal = {Radiology Advances},
  year = {2024},
  doi = {10.1093/radadv/umae008}
}
Kostenlos starten →